{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:41:05Z","timestamp":1776127265802,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012273","name":"Lotte and John Hecht Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Individuals with advanced cancer often experience high levels of distress for which there are few standardized treatment approaches. Our multidisciplinary team has combined existing evidence-based approaches into Psilocybin-assisted Existential, Attachment, and RelationaL (PEARL) therapy. PEARL therapy combines elements from psilocybin-assisted psychotherapy, including preparatory therapy sessions, a high-dose psilocybin session, and integration sessions, with important elements from evidence-based psychotherapies designed for patients with advanced cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This open-label, single-arm clinical trial will assess the acceptability, feasibility, and safety of PEARL therapy among 15 patients with advanced cancer, using qualitative and quantitative methodologies. Participants will complete self-report questionnaires at four time points pre- and post-intervention, as well as a qualitative interview one month after PEARL completion. Feasibility will be evaluated in terms of recruitment, retention, and adherence rates, while safety will be assessed based on the number of participants experiencing no serious adverse events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study will yield important information about the acceptability and feasibility of PEARL therapy and contribute to growing research around the efficacy of psychedelic-assisted therapies. PEARL therapy has the potential to improve quality of life among those with advanced disease, and careful research is needed to guide public policy, legislation, therapist training, and clinical guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>NCT06416085; 2024\u201307-16.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40814-025-01706-5","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:31:21Z","timestamp":1761654681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Candice","family":"Richardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Macgregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Hare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breffni","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SarahRose","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Buchman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Rac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lusine","family":"Abrahamyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Huszti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rinat","family":"Nissim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Hapke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-8124","authenticated-orcid":false,"given":"Sarah","family":"Hales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"issue":"Suppl 2","key":"1706_CR1","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1097\/MPH.0b013e318230e1fd","volume":"33","author":"C Lo","year":"2011","unstructured":"Lo C, Hales S, Zimmermann C, Gagliese L, Rydall A, Rodin G. Measuring death-related anxiety in advanced cancer: preliminary psychometrics of the death and dying distress scale. J Pediatr Hematol Oncol. 2011;33(Suppl 2):S140\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"1706_CR2","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.socscimed.2008.10.037","volume":"68","author":"G Rodin","year":"2009","unstructured":"Rodin G, Lo C, Mikulincer M, Donner A, Gagliese L, Zimmermann C. Pathways to distress: the multiple determinants of depression, hopelessness, and the desire for hastened death in metastatic cancer patients. Soc Sci Med. 2009;68(3):562\u20139.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1706_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/SPC.0000000000000324","volume":"12","author":"S Vehling","year":"2018","unstructured":"Vehling S, Philipp R. Existential distress and meaning-focused interventions in cancer survivorship. Curr Opin Support Palliat Care. 2018;12(1):46\u201351.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"9930","key":"1706_CR4","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","volume":"383","author":"C Zimmermann","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(13)62416-2.","journal-title":"Lancet"},{"issue":"20","key":"1706_CR5","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2016.16840","volume":"316","author":"D Kavalieratos","year":"2016","unstructured":"Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016;316(20):2104\u201314. https:\/\/doi.org\/10.1001\/jama.2016.16840.","journal-title":"JAMA"},{"key":"1706_CR6","doi-asserted-by":"crossref","unstructured":"Galushko M, Romotzky V, Voltz R. Challenges in end-of-life communication. Curr Opin Support Palliat Care. 2012;6(3). Available from: https:\/\/journals.lww.com\/co-supportiveandpalliativecare\/Fulltext\/2012\/09000\/Challenges_in_end_of_life_communication.11.aspx.","DOI":"10.1097\/SPC.0b013e328356ab72"},{"key":"1706_CR7","doi-asserted-by":"crossref","unstructured":"Hales S, Lo C, Rodin G. Managing Cancer And Living Meaningfully (CALM) therapy. In: Holland JC, Breitbart WS, Jacobsen PB, Loscalzo MJ, McCorkle R, Butow PN, editors. Psycho-Oncology. Third. New York, NY: Oxford University Press; 2015. p. 487\u201391.","DOI":"10.1093\/med\/9780199363315.003.0062"},{"key":"1706_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780190236427.001.0001","volume-title":"Managing cancer and living meaningfully: an evidence-based intervention for cancer patients and their caregivers","author":"G Rodin","year":"2021","unstructured":"Rodin G, Hales S. Managing cancer and living meaningfully: an evidence-based intervention for cancer patients and their caregivers. New York, NY: Oxford University Press; 2021."},{"key":"1706_CR9","doi-asserted-by":"crossref","unstructured":"Colosimo K, Nissim R, Pos AE, Hales S, Zimmermann C, Rodin G. \u201cDouble awareness\u201d in psychotherapy for patients living with advanced cancer. Vol. 28, Journal of Psychotherapy Integration. Colosimo, Ken: Department of Psychology, York University, Behavioural Science Building, 4700 Keele Street, Toronto, ON, Canada, M3J 1P3, kennethc@yorku.ca: Educational Publishing Foundation; 2018. p. 125\u201340.","DOI":"10.1037\/int0000078"},{"issue":"1","key":"1706_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1521\/jaap.2008.36.1.181","volume":"36","author":"G Rodin","year":"2008","unstructured":"Rodin G, Zimmermann C. Psychoanalytic reflections on mortality: a reconsideration. J Am Acad Psychoanal Dyn Psychiatry. 2008;36(1):181\u201396.","journal-title":"J Am Acad Psychoanal Dyn Psychiatry"},{"issue":"23","key":"1706_CR11","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1200\/JCO.2017.77.1097","volume":"36","author":"G Rodin","year":"2018","unstructured":"Rodin G, Lo C, Rydall A, Shnall J, Malfitano C, Chiu A, et al. Managing cancer and living meaningfully (CALM): a randomized controlled trial of a psychological intervention for patients with advanced cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36(23):2422\u201332.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"11","key":"1706_CR12","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1016\/S1470-2045(18)30415-7","volume":"19","author":"S Kaasa","year":"2018","unstructured":"Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, et al. Integration of oncology and palliative care: a Lancet Oncology Commission. Lancet Oncol. 2018;19(11):e588-653.","journal-title":"Lancet Oncol"},{"issue":"7","key":"1706_CR13","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1089\/jpm.2017.0576","volume":"21","author":"JJ Fulton","year":"2018","unstructured":"Fulton JJ, Newins AR, Porter LS, Ramos K. Psychotherapy targeting depression and anxiety for use in palliative care: a meta-analysis. J Palliat Med. 2018;21(7):1024\u201337. https:\/\/doi.org\/10.1089\/jpm.2017.0576.","journal-title":"J Palliat Med"},{"issue":"1","key":"1706_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/0269216317722123","volume":"32","author":"CH Grossman","year":"2018","unstructured":"Grossman CH, Brooker J, Michael N, Kissane D. Death anxiety interventions in patients with advanced cancer: a systematic review. Palliat Med. 2018;32(1):172\u201384.","journal-title":"Palliat Med"},{"key":"1706_CR15","doi-asserted-by":"crossref","unstructured":"Nichols DE. Psychedelics. Barker EL, editor. Pharmacol Rev. 2016 Apr 1;68(2):264 LP \u2013 355. Available from: http:\/\/pharmrev.aspetjournals.org\/content\/68\/2\/264.abstract.","DOI":"10.1124\/pr.115.011478"},{"issue":"3","key":"1706_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S2215-0366(23)00363-2","volume":"11","author":"G Gr\u00fcnder","year":"2024","unstructured":"Gr\u00fcnder G, Brand M, Mertens LJ, Jungaberle H, K\u00e4rtner L, Scharf DJ, et al. Treatment with psychedelics is psychotherapy: beyond reductionism. Lancet Psychiatry. 2024;11(3):231\u20136. https:\/\/doi.org\/10.1016\/S2215-0366(23)00363-2.","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"1706_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09540261.2018.1482261","volume":"30","author":"S Ross","year":"2018","unstructured":"Ross S. Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress. Int Rev Psychiatry. 2018;30(4):317\u201330.","journal-title":"Int Rev Psychiatry"},{"key":"1706_CR18","doi-asserted-by":"crossref","unstructured":"Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181\u201397. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27909165.","DOI":"10.1177\/0269881116675513"},{"issue":"1","key":"1706_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","volume":"68","author":"CS Grob","year":"2011","unstructured":"Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry. 2011;68(1):71\u20138. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.116.","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"1706_CR20","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol. 2016;30(12):1165\u201380.","journal-title":"J Psychopharmacol"},{"issue":"7","key":"1706_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","volume":"202","author":"P Gasser","year":"2014","unstructured":"Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, et al. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 2014;202(7):513\u201320.","journal-title":"J Nerv Ment Dis"},{"key":"1706_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.09.012","volume":"81","author":"S Reiche","year":"2018","unstructured":"Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Maji\u0107 T. Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2018;81:1\u201310.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"1706_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","volume":"34","author":"GI Agin-Liebes","year":"2020","unstructured":"Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Pont\u00e9 KL, Guss J, et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol. 2020;34(2):155\u201366.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"1706_CR24","doi-asserted-by":"publisher","first-page":"e725","DOI":"10.1016\/j.jpainsymman.2022.01.024","volume":"63","author":"LO Maia","year":"2022","unstructured":"Maia LO, Beaussant Y, Garcia ACM. The therapeutic potential of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness: a systematic review. J Pain Symptom Manage. 2022;63(6):e725\u201338.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1706_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jpainsymman.2023.06.006","volume":"66","author":"BR Lewis","year":"2023","unstructured":"Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, et al. HOPE: a pilot study of psilocybin enhanced group psychotherapy in patients with cancer. J Pain Symptom Manage. 2023;66(3):258\u201369. https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.06.006.","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"1706_CR26","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/cncr.35010","volume":"130","author":"M Agrawal","year":"2024","unstructured":"Agrawal M, Richards W, Beaussant Y, Shnayder S, Ameli R, Roddy K, et al. Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder. Cancer. 2024;130(7):1137\u201346. https:\/\/doi.org\/10.1002\/cncr.35010.","journal-title":"Cancer"},{"issue":"1","key":"1706_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75706-1","volume":"10","author":"PE Wolfson","year":"2020","unstructured":"Wolfson PE, Andries J, Feduccia AA, Jerome L, Wang JB, Williams E, et al. MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study. Sci Rep. 2020;10(1):20442.","journal-title":"Sci Rep"},{"key":"1706_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100538","volume":"27","author":"BT Anderson","year":"2020","unstructured":"Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, et al. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study. EClinicalMedicine. 2020;27:100538.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"1706_CR29","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/cncr.35024","volume":"130","author":"Y Beaussant","year":"2024","unstructured":"Beaussant Y, Tarbi E, Nigam K, Miner S, Sager Z, Sanders JJ, et al. Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: qualitative analysis. Cancer. 2024;130(7):1147\u201357. https:\/\/doi.org\/10.1002\/cncr.35024.","journal-title":"Cancer"},{"issue":"7","key":"1706_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1177\/0269881118754710","volume":"32","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, et al. Psychedelics and the essential importance of context. J Psychopharmacol. 2018;32(7):725\u201331.","journal-title":"J Psychopharmacol"},{"issue":"10","key":"1706_CR31","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1089\/jpm.2019.0603","volume":"23","author":"Y Beaussant","year":"2020","unstructured":"Beaussant Y, Sanders J, Sager Z, Tulsky JA, Braun IM, Blinderman CD, et al. Defining the roles and research priorities for psychedelic-assisted therapies in patients with serious illness: expert clinicians\u2019 and investigators\u2019 perspectives. J Palliat Med. 2020;23(10):1323\u201334.","journal-title":"J Palliat Med"},{"issue":"7","key":"1706_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1177\/02698811231180276","volume":"37","author":"OR Hovmand","year":"2023","unstructured":"Hovmand OR, Poulsen ED, Arnfred S, Storeb\u00f8 OJ. Risk of bias in randomized clinical trials on psychedelic medicine: a systematic review. J Psychopharmacol. 2023;37(7):649\u201359.","journal-title":"J Psychopharmacol"},{"key":"1706_CR33","unstructured":"American Psychedelic Practitioners Association and BrainFutures. Professional practice guidelines for psychedelic-assisted therapy. 2023. Available from: https:\/\/www.appa-us.org\/standards-and-guidelines\/professionalpracticeguidelines."},{"issue":"5","key":"1706_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1752-8062.2011.00347.x","volume":"4","author":"CG Moore","year":"2011","unstructured":"Moore CG, Carter RE, Nietert PJ, Stewart PW. Recommendations for planning pilot studies in clinical and translational research. Clin Transl Sci. 2011;4(5):332\u20137.","journal-title":"Clin Transl Sci"},{"issue":"3","key":"1706_CR35","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25(3):1057\u201373.","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"1706_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-015-0026-y","volume":"1","author":"A O\u2019Cathain","year":"2015","unstructured":"O\u2019Cathain A, Hoddinott P, Lewin S, Thomas KJ, Young B, Adamson J, et al. Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers. Pilot Feasibility Stud. 2015;1(1):32. https:\/\/doi.org\/10.1186\/s40814-015-0026-y.","journal-title":"Pilot Feasibility Stud"},{"key":"1706_CR37","unstructured":"U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) v5.0. 2017. Available from: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50. Cited 2024 Jul 1."},{"issue":"1","key":"1706_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-10-1","volume":"10","author":"L Thabane","year":"2010","unstructured":"Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1. https:\/\/doi.org\/10.1186\/1471-2288-10-1.","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"1706_CR39","doi-asserted-by":"publisher","first-page":"e013537","DOI":"10.1136\/bmjopen-2016-013537","volume":"7","author":"KNL Avery","year":"2017","unstructured":"Avery KNL, Williamson PR, Gamble C, Connell Francischetto E, Metcalfe C, Davidson P, et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017;7(2):e013537. Available from: https:\/\/bmjopen.bmj.com\/content\/7\/2\/e013537.abstract.","journal-title":"BMJ Open"},{"issue":"2","key":"1706_CR40","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"issue":"1","key":"1706_CR41","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jpainsymman.2014.04.012","volume":"49","author":"S Krause","year":"2015","unstructured":"Krause S, Rydall A, Hales S, Rodin G, Lo C. Initial validation of the death and dying distress scale for the assessment of death anxiety in patients with advanced cancer. J Pain Symptom Manage. 2015;49(1):126\u201334.","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"1706_CR42","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"10","key":"1706_CR43","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"},{"issue":"2","key":"1706_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/082585979100700202","volume":"7","author":"E Bruera","year":"1991","unstructured":"Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton symptom assessment system (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6\u20139.","journal-title":"J Palliat Care"},{"issue":"4","key":"1706_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/082585970402000402","volume":"20","author":"DW Kissane","year":"2004","unstructured":"Kissane DW, Wein S, Love A, Lee XQ, Kee PL, Clarke DM. The demoralization scale: a report of its development and preliminary validation. J Palliat Care. 2004;20(4):269\u201376.","journal-title":"J Palliat Care"},{"key":"1706_CR46","unstructured":"Brennan KA, Clark CL, Shaver PR. Self-report measurement of adult attachment: an integrative overview. Attachment theory and close relationships. New York, NY, US: The Guilford Press; 1998. p. 46\u201376."},{"issue":"1","key":"1706_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1207\/S15324796ABM2401_06","volume":"24","author":"AH Peterman","year":"2002","unstructured":"Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy\u2013Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med. 2002;24(1):49\u201358.","journal-title":"Ann Behav Med"},{"issue":"1","key":"1706_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1017\/S1478951504040027","volume":"2","author":"KE Steinhauser","year":"2004","unstructured":"Steinhauser KE, Clipp EC, Bosworth HB, McNeilly M, Christakis NA, Voils CI, et al. Measuring quality of life at the end of life: validation of the QUAL-E. Palliat Support Care. 2004;2(1):3\u201314.","journal-title":"Palliat Support Care"},{"issue":"12","key":"1706_CR49","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1002\/1097-0142(20000615)88:12<2868::AID-CNCR30>3.0.CO;2-K","volume":"88","author":"B Rosenfeld","year":"2000","unstructured":"Rosenfeld B, Breitbart W, Galietta M, Kaim M, Funesti-Esch J, Pessin H, et al. The schedule of attitudes toward hastened death: measuring desire for death in terminally ill cancer patients. Cancer. 2000;88(12):2868\u201375.","journal-title":"Cancer"},{"issue":"6","key":"1706_CR50","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/1740774512465064","volume":"9","author":"J Younger","year":"2012","unstructured":"Younger J, Gandhi V, Hubbard E, Mackey S. Development of the Stanford Expectations of Treatment Scale (SETS): a tool for measuring patient outcome expectancy in clinical trials. Clin Trials. 2012;9(6):767\u201376.","journal-title":"Clin Trials"},{"key":"1706_CR51","doi-asserted-by":"crossref","unstructured":"Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol. 2015\/10\/06. 2015;29(11):1182\u201390. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26442957.","DOI":"10.1177\/0269881115609019"},{"issue":"3","key":"1706_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187(3):268\u201392.","journal-title":"Psychopharmacology"},{"issue":"9","key":"1706_CR53","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1177\/0269881119855974","volume":"33","author":"L Roseman","year":"2019","unstructured":"Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R. Emotional breakthrough and psychedelics: validation of the emotional breakthrough inventory. J Psychopharmacol. 2019;33(9):1076\u201387.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"1706_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/07067437221111371","volume":"68","author":"JD Rosenblat","year":"2023","unstructured":"Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force report: serotonergic psychedelic treatments for major depressive disorder. Can J Psychiatry. 2023;68(1):5\u201321.","journal-title":"Can J Psychiatry"},{"issue":"1","key":"1706_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40814-020-00712-z","volume":"6","author":"T Baldeh","year":"2020","unstructured":"Baldeh T, MacDonald T, Kosa SD, Lawson DO, Stalteri R, Olaiya OR, et al. More pilot trials could plan to use qualitative data: a meta-epidemiological study. Pilot Feasibility Stud. 2020;6(1):164. https:\/\/doi.org\/10.1186\/s40814-020-00712-z.","journal-title":"Pilot Feasibility Stud"},{"issue":"1","key":"1706_CR56","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/MLR.0000000000001664","volume":"60","author":"JA Teresi","year":"2022","unstructured":"Teresi JA, Yu X, Stewart AL, Hays RD. Guidelines for designing and evaluating feasibility pilot studies. Med Care. 2022;60(1):95\u2013103.","journal-title":"Med Care"},{"issue":"8","key":"1706_CR57","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00213-024-06620-x","volume":"241","author":"JS Aday","year":"2024","unstructured":"Aday JS, Horton D, Fernandes-Osterhold G, O\u2019Donovan A, Bradley ER, Rosen RC, et al. Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology. 2024;241(8):1517\u201326.","journal-title":"Psychopharmacology"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-025-01706-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-025-01706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:07:12Z","timestamp":1761696432000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-025-01706-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1186\/s40814-025-01706-5","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"26 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has received ethical approval from the University Health Network Research Ethics Board. Study participants will provide informed consent and sign Board-approved consent forms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}